Patents by Inventor Christer Alstermark

Christer Alstermark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080221063
    Abstract: The invention relates to heterocyclic derivatives of formula (I), Chemical formula should be inserted here. Please see paper copy wherein R1 is hydrogen or C1-3alkyl; R2 is selected from hydroxy, C1-5alkyl, carboxy, cyano, tetrazolyl, N—C1-5alkyltetrazolyl, oxazolyl, C1-5oxazolyl, isoxazolyl, C1-5 isoxazolyl, hydroxyC1-5alkyl, carboxy C1-5alkyl, C1-5alkoxyoxo C1-5alkyl, carbamoyl, C1-5alkylcarbamoyl, di(C1-5alkyl)carbamoyl, C1-5alkylcarbamoyl C1-4alkyl, hydroxy C1-5alkylcarbamoyl, C1-5alkoxy C1-5alkylcarbamoyl; —C1-5alkyl-Y1, —COOCHR17R18 and —CONR17R18; and R3 is hydrogen or halogen; or a pharmaceutically acceptable salt thereof, said compounds possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals.
    Type: Application
    Filed: July 5, 2006
    Publication date: September 11, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christer Alstermark, Kjell Andersson, Ulf Fahlander, Kenneth Granberg
  • Publication number: 20080214495
    Abstract: The invention relates to compounds of formula (I), wherein R1 and R3 are independently selected from carbon and nitrogen; R2 is oxo or thioxo; n is 0, 1 or 2; each R10 is independently selected from hydrogen and C1-3alkyl; R4 and R5 are each selected from carbon and nitrogen, wherein at least one of R4 and R5 is nitrogen; R6 is hydrogen or oxo; R7 is an aliphatic, partially saturated or aromatic carbocyclic ring, said carbocyclic ring having 0, 1 or 2 hetero nitrogen; m is 0, 1 or 2; each R11 is independently selected from hydrogen, hydroxy, oxo, C1-5alkyl, carboxy, hydroxyC1-5alkyl, carboxyC1-5alkyl, C1-5alkoxy-oxoC1-5alkyl, carbamoyl, C1-5alkylcarbamoyl, di (C1-5 alkyl)carbamoyl, carbamoylC1-4alkyl,C1-5alkylcarbamoylC1-4alkyl, di(C1-5alkyl)carbamoylC1-4alkyl, hydroxyC1-5alkylcarbamoyl, C1-5 alkoxyC1-5alkylcarbamoyl, hydroxyC1-5alkylcarbamoylC1-4alkyl, C1-5alkoxyC1-5 alkylcarbamoylC1-4 alkyl, CONR80(CH2)xS(O)pR90, CONH(CH2)qNR100R100, —C1-5 alkyl-Y1, —COOCHR170R180 and —CON R170R180; R8 is a bond, C1-4alkyle
    Type: Application
    Filed: July 5, 2006
    Publication date: September 4, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christer Alstermark, Kosrat Amin, Kjell Andersson, Yantao Chen, Ulf Fahlander, Kevin Michael Foote, Kenneth Granberg, Daniel Hovdal
  • Publication number: 20080200431
    Abstract: The invention relates to compounds of formula (I), Chemical formula should be inserted here.
    Type: Application
    Filed: July 5, 2006
    Publication date: August 21, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christer Alstermark, Kosrat Amin, Kjell Andersson, Ulf Fahlander, Kenneth Granberg, Daniel Hovdal
  • Publication number: 20040229900
    Abstract: There is provided compounds of formula I, 1
    Type: Application
    Filed: June 21, 2004
    Publication date: November 18, 2004
    Applicant: AstraZeneca AB
    Inventors: Christer Alstermark, Kjell Andersson, Annika Bjore, Magnus Bjorsne, Eva-Lotte Lindstedt Alstermark, Goran N. Nilsson, Magnus Polla, Gert Strandlund, Yiva Ortengren
  • Patent number: 6291475
    Abstract: There is provided a compound of formula I, wherein R1, R2, R9, R10, R11, R12, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 18, 2001
    Assignee: AstraZeneca AB
    Inventors: Christer Alstermark, Annika Björe, Magnus Björsne, Marianne Frantsi, Torbjörn Halvarsson, Kurt-Jürgen Hoffmann, Eva-Lotte Lindstedt, Magnus Polla, Gert Strandlund